GDM(SZ:002636)2023-04-28 16:00Financial Performance - The company's operating revenue for 2022 was approximately ¥3.76 billion, a decrease of 36.17% compared to ¥5.89 billion in 2021[17]. - The net profit attributable to shareholders for 2022 was approximately ¥87.10 million, down 87.38% from ¥690.19 million in 2021[17]. - The net cash flow from operating activities was approximately ¥455.73 million, a decline of 38.59% compared to ¥742.13 million in 2021[17]. - Basic earnings per share for 2022 were ¥0.120, down 87.34% from ¥0.948 in 2021[17]. - The company reported a significant decline in net profit after deducting non-recurring gains and losses, with a net profit of approximately ¥7.25 million, down 98.86% from ¥635.93 million in 2021[17]. - The weighted average return on net assets for 2022 was 2.44%, a decrease of 19.06% from 21.50% in 2021[17]. - Total operating revenue for 2022 was approximately ¥3.76 billion, a decrease of 36.1% compared to ¥5.89 billion in 2021[127]. - Total operating costs for 2022 were approximately ¥3.73 billion, down 26.0% from ¥5.05 billion in 2021[127]. - The company's total liabilities decreased from ¥100.18 billion in 2021 to ¥74.20 billion in 2022, a reduction of 26.0%[133]. - Total equity increased from ¥2.39 billion in 2021 to ¥2.90 billion in 2022, reflecting a growth of 21.1%[133]. Revenue Breakdown - The main business segment, copper-clad laminates, produced 37.06 million sheets, down 10.67% year-on-year, and sold 36.83 million sheets, down 10.57% year-on-year, generating revenue of CNY 3,220.90 million, a decline of 40.45%[35]. - The revenue from the electronic components manufacturing sector, which includes copper-clad laminates, was approximately ¥3.47 billion, accounting for 92.19% of total revenue, and decreased by 38.37% year-on-year[45]. - The revenue from the copper-clad laminates and related products was approximately ¥3.22 billion, which is 85.65% of total revenue, showing a decline of 40.45% compared to the previous year[45]. - The medical health segment reported revenue of CNY 293.54 million, an increase of 10.31% year-on-year[35]. - The PCB segment generated revenue of CNY 175.42 million, falling short of annual expectations[35]. Cash Flow and Liquidity - The net cash flow from operating activities for 2022 was ¥455,725,256.93, a decrease of 38.7% compared to ¥742,126,022.15 in 2021[142]. - Cash and cash equivalents at the end of 2022 amounted to ¥926,642,666.66, down from ¥1,485,217,736.82 at the end of 2021, indicating a decrease of 37.5%[144]. - The total cash inflow from investment activities decreased to ¥2,517,376,647.07 in 2022 from ¥4,220,933,455.07 in 2021, representing a decline of 40.5%[142]. - The company reported a total cash outflow from financing activities of ¥136,348,137.43 in 2022, compared to ¥253,075,298.67 in 2021, a reduction of 46.1%[144]. Assets and Liabilities - Total assets at the end of 2022 were approximately ¥6.24 billion, a decrease of 9.05% from ¥6.87 billion at the end of 2021[17]. - The total liabilities decreased to CNY 2,547,676,767.97 from CNY 3,200,573,043.58, a reduction of about 20.4%[117]. - The company's current assets decreased to CNY 3,784,511,501.27 from CNY 4,822,613,357.29, reflecting a decline of approximately 21.5%[115]. - The company's inventory decreased from CNY 425,513,210.37 to CNY 394,825,336.13, a decline of about 7.2%[113]. Shareholder Information - The largest shareholder, Shanghai Donglin Investment Development Co., Ltd., holds 39.83% of the shares, totaling 289,926,000 shares[65]. - The second largest shareholder, Jin'an International Technology Group Co., Ltd., holds 25.65% of the shares, totaling 186,732,000 shares[65]. - The total number of shareholders at the end of the reporting period is 50,643[65]. - The company has not experienced any changes in its controlling shareholder during the reporting period[68]. Strategic Initiatives - The company is focusing on expanding its product offerings in the electronic materials sector, including new technologies and applications in emerging industries like 5G and AI[31]. - The company has established a strategic partnership with quality suppliers to ensure supply chain security and efficiency[32]. - The company aims to optimize its product structure and increase market supply capacity through the gradual production of additional lines in the Anhui project[36]. - The company plans to focus on market expansion and new product development as part of its future strategy[134]. - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product offerings[163]. Audit and Compliance - The company's financial statements received a standard unqualified audit opinion, affirming that they fairly present the financial position as of December 31, 2022[80]. - The audit identified the impairment of accounts receivable as a key audit matter due to the significant estimates involved[105]. - The management's assessment of the recoverability of accounts receivable is critical and involves significant judgment[105]. Research and Development - The company holds 82 invention patents and 233 utility model patents, emphasizing its commitment to technological innovation[43]. - The company aims to enhance its technological capabilities through ongoing research and development initiatives[163].